TELMISARTAN | A090032 | GLENMARK PHARMACEUTICALS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Unichem Pharmaceuticals (USA), Inc. FDA-2025-P-7054 · 7 docket documents Unichem Pharmaceuticals (USA), Inc. filed this citizen petition requesting that the FDA determine whether MICARDIS (Telmisartan Tablets, 20 mg and 80 mg) under NDA N020850, held by Boehringer Ingelheim, was voluntarily withdrawn for safety or effectiveness reasons. The petitioner seeks confirmation | 505(q) | 2025-12-15 | Granted | Unichem Pharmaceuticals (USA), Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1600
per ea
Lowest NADAC/Unit
$0.1070
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462020013TELMISARTAN 40 MG TABLET | $0.1600 | EA | Generic | — | 2026-06-17 |
| 68462020090TELMISARTAN 40 MG TABLET | $0.1600 | EA | Generic | — | 2026-06-17 |
| 68462020030TELMISARTAN 40 MG TABLET | $0.1600 | EA | Generic | — | 2026-06-17 |
| 68462020190TELMISARTAN 80 MG TABLET | $0.1485 | EA | Generic | — | 2026-06-17 |
| 68462020113TELMISARTAN 80 MG TABLET | $0.1485 | EA | Generic | — | 2026-06-17 |
| 68462020130TELMISARTAN 80 MG TABLET | $0.1485 | EA | Generic | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.